EichorEICHOR
Location: Fargo Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Fargo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Sanford Fargo Medical Center ( Site 0039) · Merck Sharp & Dohme LLC · NCT04165070Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Sanford Fargo Medical Center-Roger Maris Cancer Center ( Sit · Merck Sharp & Dohme LLC · NCT06393374A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Sanford Broadway Medical Center · National Cancer Institute (NCI) · NCT05099003Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Sanford Broadway Medical Center · National Cancer Institute (NCI) · NCT06172296Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Sanford Broadway Medical Center · NRG Oncology · NCT05624996Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Essentia Health Cancer Center-South University Clinic · Alliance for Clinical Trials in Oncology · NCT07321652A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Sanford Broadway Medical Center · Children's Oncology Group · NCT06368817A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Sanford Broadway Medical Center · National Cancer Institute (NCI) · NCT05691478A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Sanford Broadway Medical Center · Children's Oncology Group · NCT04322318A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Sanford Fargo Medical Center-Roger Maris Cancer Center ( Sit · Merck Sharp & Dohme LLC · NCT06077760Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Essentia Health Cancer Center-South University Clinic · SWOG Cancer Research Network · NCT06769126Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Sanford Roger Maris Cancer Center · NRG Oncology · NCT05946213A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Inmagene Site 10 · Inmagene LLC · NCT07037901A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Lillestol Research · Eli Lilly and Company · NCT05986292Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Essentia Health Cancer Center-South University Clinic · NRG Oncology · NCT05174169SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Sanford Medical Center Fargo · SAb Biotherapeutics, Inc. · NCT07187531Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Sanford South University Medical Center · Alliance for Clinical Trials in Oncology · NCT06632327Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Sanford Broadway Medical Center · Alliance for Clinical Trials in Oncology · NCT06931340KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · Sanford Health Roger Maris Cancer Center ( Site 0039) · Merck Sharp & Dohme LLC · NCT07252739ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Essentia Health Cancer Center-South University Clinic · Alliance for Clinical Trials in Oncology · NCT06876714This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Red River Research Partners - Fargo- Site Number : 8400037 · Sanofi · NCT07290803A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Phase 2 · Lillestol Research, LLC · Boehringer Ingelheim · NCT07662122Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · Sanford Roger Maris Cancer Center · Exelixis · NCT06943755Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Essentia Health Cancer Center-South University Clinic · Canadian Cancer Trials Group · NCT06592924Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Phase N/A · Sanford Health · Duke University · NCT02418442A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Sanford Broadway Medical Center · Children's Oncology Group · NCT04293562E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Essentia Health Cancer Center-South University Clinic · NRG Oncology · NCT06748222Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Essentia Health Cancer Center-South University Clinic · National Cancer Institute (NCI) · NCT06649812SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Essentia Health Cancer Center-South University Clinic · Alliance for Clinical Trials in Oncology · NCT06632977
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.